Nu-Med Plus Stock Price, News & Analysis
Company Description
Nu-Med Plus (OTC Link: NUMD) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $852.2K.
NUMD stock has declined 81.1% over the past year. Shares last traded at $0.0102.
On a trailing twelve-month basis, Nu-Med Plus and diluted earnings per share of $0.00.
This page provides a comprehensive overview of NUMD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Nu-Med Plus (NUMD) stock last traded at $0.0102. Over the past 12 months, the stock has lost 81.1%. At a market capitalization of $852.2K, NUMD is classified as a micro-cap stock with approximately 83.5M shares outstanding.
Latest News
SEC Filings
Nu-Med Plus has filed 4 recent SEC filings, including 2 Form 10-Q, 1 Form 10-K, 1 Form NT 10-K. The most recent filing was submitted on May 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NUMD SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Nu-Med Plus (NUMD) currently stands at 41.5 thousand shares, up 16.4% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has increased by 16.4%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Nu-Med Plus (NUMD) currently stands at 1.0 days, down 72.6% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 892.2 days.
NUMD Company Profile & Sector Positioning
Nu-Med Plus (NUMD) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.